세계의 감염 감시 솔루션 시장 규모는 2024년 5억 5,721만 달러로, 2030년까지 예측기간 중 CAGR 11.16%로 견조한 성장이 예측되고 있습니다. 감염 감시 솔루션은 병원을 포함한 의료시설이 환자 데이터를 주 및 연방 당국에 보고하는 데 사용하는 소프트웨어입니다. 이러한 솔루션은 병원 감염에 대한 데이터를 수집하고, 감염 패턴을 연구하고, 커뮤니티 내에서의 감염 확대를 규제함으로써 의료 산업에서 중요한 역할을 합니다. 원내 감염이란, 병원이나 헬스케어 센터내에서 개인에 감염하는 감염증입니다. 이 소프트웨어는 감염이 발생하면 병원의 인터넷 프로토콜(IP) 주소에 신속하게 경고합니다. 이를 통해 HAI 전문가와 간호사는 감염된 환자에게 적절한 치료를 신속하게 제공할 수 있어 탈출을 예방할 수 있습니다. 감염 모니터링 솔루션은 건강 관리 시설에서 건강 관리 감염(HAI)의 효과적인 관리를 촉진하는 중요한 프로그램입니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2026-2030년 |
| 시장 규모 : 2024년 | 5억 5,721만 달러 |
| 시장 규모 : 2030년 | 10억 4,315만 달러 |
| CAGR : 2025-2030년 | 11.16% |
| 급성장 부문 | 병원 |
| 최대 시장 | 북미 |
예를 들어, 2024년 미국의 병원 데이터를 분석한 연구에서는 항균제 내성(AMR)과 관련된 원내 감염이 COVID-19 팬데믹 중에 32% 증가했고, 팬데믹 후의 감염률은 팬데믹 전 수준에 비해 13% 높게 유지되는 것으로 나타났습니다. 이 연구 결과는 유행이 AMR에 미치는 지속적인 영향과 지속적인 감염 조절과 항균제 스튜어드십의 필요성을 강조합니다. HAI의 일반적인 예로는 폐렴, 소화기 질환, 요로 감염, 1차 혈류 감염, 수술 후 감염 등이 있습니다. HAI의 다발은 세계 정부에 중대한 관심사이며, 이러한 사고를 효과적으로 관리하고 감소시키는 것을 목적으로 한 정책의 개발로 이어지고 있습니다. 영국 의료보건국의 2025년 보고서에 따르면, 의료관련 감염은 환자의 7.6%에서 인정되었으며, 2016년에 비해 1% 증가했습니다. 이 설문조사는 증가 추세가 우려되는 것으로 밝혀졌으며 영국의 건강 관리 환경 전반에서 감염 예방 및 관리 대책을 강화할 필요성을 강조하고 있습니다.
원내 감염 증가
소규모 의료 조직에서 도입 비용이 높습니다.
클라우드 기반 소프트웨어 솔루션
Global Infection Surveillance Solutions Market was valued at USD 557.21 Million in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 11.16% through 2030F. An infection surveillance solution is a software used by healthcare facilities, including hospitals, to report patient data to state and federal authorities. These solutions play a crucial role in the healthcare industry by collecting data on nosocomial infections, studying infection patterns, and regulating their spread within the community. Nosocomial infections are infections transmitted to individuals within hospitals or healthcare centers. This software promptly alerts hospital Internet Protocol (IP) addresses in the event of infection occurrences. This enables HAI specialists and nurses to promptly provide appropriate treatment to infected patients, preventing outbreaks. Infection surveillance solutions are vital programs that facilitate the effective management of Healthcare-Acquired Infections (HAIs) in healthcare facilities.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 557.21 Million |
| Market Size 2030 | USD 1043.15 Million |
| CAGR 2025-2030 | 11.16% |
| Fastest Growing Segment | Hospitals |
| Largest Market | North America |
For instance, in 2024, a study analyzing U.S. hospital data revealed that hospital-acquired infections linked to antimicrobial resistance (AMR) rose by 32% during the COVID-19 pandemic and remain 13% higher post-pandemic compared to pre-pandemic levels. The findings underscore the lasting impact of the pandemic on AMR and the need for sustained infection control and antimicrobial stewardship. Common examples of HAIs include pneumonia, gastrointestinal illness, urinary tract infections, primary bloodstream infections, and post-surgical infections. The high incidence of HAIs is a significant concern for governments worldwide, leading to the development of policies aimed at effectively managing and reducing these incidents. According to the UK Health Security Agency's 2025 report, healthcare-associated infections were found in 7.6% of patients-marking a 1% rise compared to 2016. The survey highlights a concerning upward trend, emphasizing the need for strengthened infection prevention and control measures across healthcare settings in the UK.
Key Market Drivers
Increasing Prevalence of Hospital-Acquired Infections
The increasing prevalence of hospital-acquired infections (HAIs) is driving the demand for infection surveillance solutions. Hospital-acquired infections, also known as healthcare-associated infections, are infections that patients acquire while receiving medical treatment in healthcare facilities. These infections can lead to prolonged hospital stays, increased healthcare costs, patient discomfort, and, in severe cases, even mortality. In response to this growing concern, infection surveillance solutions are being sought after to help prevent, monitor, and manage HAIs. HAIs pose a significant threat to patient safety and well-being. The rising awareness of these concerns has prompted healthcare facilities to prioritize infection control. For instance, in 2024, healthcare-associated infections impact approximately 4.3 million patients annually in hospitals across the EU/EEA. These infections pose significant challenges to patient safety, increase hospital stays, and contribute to higher healthcare costs. Reducing their incidence remains a critical priority for healthcare systems, requiring improved infection control practices and enhanced surveillance measures throughout the region.
The increasing emphasis on hospital safety is driving the market for infection control surveillance solutions. Hospitals are actively seeking ways to enhance patient safety and reduce infection rates through improved surveillance strategies. This transformation commenced in the late 2000s with the introduction of electronic medical record systems, which allowed for more efficient and accurate patient data collection. Presently, hospitals are investing in advanced solutions to detect and predict infections, implement evidence-based protocols, and monitor outcomes over time. These solutions leverage data analytics, AI, ML, and predictive modeling to facilitate accurate identification and mitigation of infection risks. Apart from enhancing patient safety, these solutions offer potential benefits such as cost reduction, operational efficiency improvement, and optimization of care quality.
Key Market Challenges
High Cost of Deployment for Small Healthcare Organizations
The high cost of deployment for small healthcare organizations is a significant factor restraining the growth of Infection Surveillance Solutions (ISS). These solutions often require initial investment in technology, infrastructure, staff training, and ongoing maintenance. For small healthcare organizations with limited budgets and resources, the cost of implementing and sustaining infection surveillance solutions can be a barrier to adoption. Small healthcare organizations often operate with tighter budgets compared to larger institutions. The high upfront and ongoing costs associated with infection surveillance solutions can strain their financial resources, making it difficult to allocate funds for implementation. Small healthcare organizations may need to prioritize their resources for essential services and treatments. Investing in infection surveillance solutions might divert resources away from other critical needs, making the decision challenging. Beyond the initial deployment, infection surveillance solutions require ongoing maintenance, updates, and technical support. Small healthcare organizations might struggle to allocate resources for these continuous operational needs.
Key Market Trends
Cloud-based Software Solutions
Cloud-based software solutions are expected to significantly boost the Infection Surveillance Solutions (ISS) market in the future. Cloud technology offers a range of benefits that align well with the needs of healthcare organizations seeking efficient and scalable infection surveillance solutions. For instance, according to a 2022 article, 94% of companies worldwide have adopted cloud computing. This widespread adoption reflects the growing reliance on cloud-based technologies to enhance scalability, improve efficiency, and support digital transformation across various industries, making cloud computing a critical component of modern business operations. Cloud-based solutions offer scalability to accommodate the varying needs of healthcare organizations, whether they are small clinics or large hospitals. As the demand for infection surveillance solutions grows, cloud platforms can easily scale up to handle increased data volume and user activity. Traditional on-premises software solutions require significant investments in hardware, servers, and IT infrastructure. Cloud-based solutions eliminate these upfront costs, making ISS more accessible to healthcare organizations with limited resources. Cloud-based solutions are typically quicker to implement compared to on-premises alternatives. This is particularly advantageous for healthcare organizations looking to deploy infection surveillance solutions rapidly. Cloud-based solutions provide remote access to infection surveillance data for authorized personnel. Healthcare professionals can securely access and monitor infection data from various locations, enabling more efficient and timely interventions. Cloud-based infection surveillance solutions enable real-time monitoring of infection trends, allowing healthcare organizations to respond promptly to potential outbreaks and implement necessary interventions.
In this report, the Global Infection Surveillance Solutions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Infection Surveillance Solutions Market.
Global Infection Surveillance Solutions market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: